(Press-News.org) New research has shown a new type of inhibitor drug could prevent microvascular diabetic complications, such as diabetic eye and kidney disease. The University of Bristol-led research is published in Cardiovascular Diabetology.
Diabetes, a disease which results in uncontrolled blood glucose levels, is estimated to affect one in 11 adults worldwide. Even when managed, this common disease can result in life-altering complications, impacting the small blood vessels of the body, known as the microvasculature.
While treatments are available for patients who develop microvascular complications, such as diabetic eye and kidney disease, these treatments do not fully delay progression. Eventually they may result in blindness and kidney failure in patients.
The research team was interested in the protective lining of all blood vessels, called the glycocalyx. This lining is known to be damaged in diabetes. The researchers showed in two mouse models that by preventing damage to this protective layer, the development of diabetic eye and kidney disease could be stopped.
This is achieved using a ‘heparanase inhibitor’. Heparanase acts likes a pair of scissors, damaging the glycocalyx lining. Heparanase inhibitors stop this damage from happening. The research team has developed a novel class of these drugs, which could be successfully developed as a medication to treat patients.
Dr Rebecca Foster, Associate Professor of Microvascular Medicine in the Bristol Medical School: Translational Health Sciences (THS), and senior author of the study, said: “Our findings are exciting as we have shown that one type of medication might be able to prevent different diabetic complications, which is a global health problem for adults living with diabetes.”
Dr Monica Gamez, Research Associate in the Bristol Medical School (THS) and corresponding author, added: “We are currently conducting research to advance our novel class of inhibitors to clinical use. With over 8% of the global adult population currently living with diabetes, we hope patients could benefit from our findings in the future.”
The study was funded by the Medical Research Council [MRC].
Paper
‘Heparanase inhibition as a systemic approach to protect endothelial glycocalyx and prevent microvascular complications in diabetes’ by Monica Gamez,, Rebecca R. Foster et al. in Cardiovascular Diabetology [open access]
END
New drug could prevent diabetic eye and kidney disease in people with diabetes
2024-02-02
ELSE PRESS RELEASES FROM THIS DATE:
UT research breaking records, growing impact in Tennessee and beyond
2024-02-02
The University of Tennessee, Knoxville, continued to expand its impact and research footprint last year, breaking university records for both research expenditures and sponsored project awards for the second straight year.
Since 2019, UT has more than doubled its sponsored project awards, reaching a record $428 million in the fiscal year that ended in June 2023. The university also reported $339 million in research expenditures in fiscal year 2023, an increase of nearly $15 million over fiscal year 2022 and the highest amount in UT history. Research expenditures include internal and external funds that support UT research ...
Rare 3D fossils show that some early trees had forms unlike any you’ve ever seen
2024-02-02
In the fossil record, trees typically are preserved with only their trunks. They don’t usually include any leaves to show what their canopies and overall forms may have looked like. But now, researchers reporting in the journal Current Biology on February 2 describe fossilized trees from New Brunswick, Canada with a surprising and unique three-dimensional crown shape.
“The way in which this tree produced hugely long leaves around its spindly trunk, and the sheer number over a short length of trunk, is startling,” says Robert Gastaldo of Colby College in Waterville, Maine.
The forms taken by these ...
Fruit flies give further insight into evolution of male genitalia driven by sexual selection
2024-02-02
Embargoed until 11am ET USA/4pm GMT UK on Friday 2 February (Current Biology embargo)
-With pictures-
Fruit flies have provided scientists with new insight into the genetic basis for the rapid evolution of male external genitalia driven by sexual selection.
Secondary sexual characteristics such as peacocks’ tails and the male external genitalia of insects are known to be among the fastest evolving animal body parts.
It is thought that this is driven by sexual selection including through female choice and the different evolutionary needs of each sex to find the right mate and maximise their fitness.
Now scientists at Durham University and Oxford ...
Availability of mental telehealth services in the US
2024-02-02
About The Study: The findings of this study of 1,404 mental health treatment facilities indicate that there were no differences in the availability of mental telehealth services based on the prospective patient’s clinical condition, perceived race or ethnicity, or sex; however, differences were found at the facility-, county-, and state-level. These findings suggest widespread disparities in who has access to which telehealth services throughout the U.S.
Authors: Jonathan Cantor, Ph.D., of the RAND Corporation in Santa Monica, California, is the corresponding author.
To access the embargoed study: Visit ...
Risk of venous thromboembolic events after surgery for cancer
2024-02-02
About The Study: This study including 432,000 patients who underwent major surgery for eight cancer types found an increased rate of venous thromboembolism associated with cancer surgery. The risk persisted for about two to four months postoperatively but varied between cancer types. The increased rate is likely explained by the underlying cancer disease and adjuvant treatments. The results highlight the need for individualized venous thromboembolism risk evaluation and prophylaxis regimens for patients undergoing different surgery for different cancers.
Authors: Johan ...
Geographic differences in telehealth found among mental health clinics
2024-02-02
Telehealth availability for mental health care varies significantly across states -- from less than half of treatment facilities contacted in states like Mississippi and South Carolina to every facility contacted in states like Maine and Oregon, according to a new RAND study.
Researchers found there were differences in services offered depending on whether a mental health treatment facility was located in in a rural or metropolitan area.
The types of services offered -- and the types of telehealth modalities available -- also varied widely among ...
Changes in health care access and preventive health screenings by race and ethnicity
2024-02-02
About The Study: The results of this study of 89,000 adults suggest that wellness visits and preventive health screenings in the U.S. have not returned to pre-pandemic levels. Screening rates for blood pressure, cholesterol, blood glucose, and common cancers were lower in 2021 versus 2019, and varied across racial and ethnic groups, with Asian adults experiencing the most pronounced declines. These findings support the need for public health efforts to increase the use of preventive health screenings among eligible adults.
Authors: Rishi K. Wadhera, ...
New therapeutic strategy for metastatic prostate cancer patients resistant to standard treatment
2024-02-02
A team of researchers from the Badalona Applied Research Group in Oncology (B·ARGO) and the Urologic Tumours Unit of the Institut Català d'Oncologia (ICO) and the Germans Trias i Pujol Research Institute (IGTP) have found a new therapeutic strategy for patients with a specific subtype of metastatic prostate cancer resistant to standard chemotherapy treatment with docetaxel.
In this study, published in the journal Frontiers in Pharmacology, they propose a new treatment based on a combination of kinase inhibitors in patients who inevitably stop responding to docetaxel. The team found that resistance to this drug is associated with the hyperactivation ...
Audiogene, the first clinical trial in France for a gene therapy to treat hearing loss in children
2024-02-02
The aim of this clinical trial, which has just received approval in France, is to assess the safety and efficacy of a new gene therapy drug in children aged between 6 and 31 months with profound hearing loss. Audiogene was developed by a French consortium composed of teams from the Hearing Institute, an Institut Pasteur research center; the ENT Department and Pediatric Audiology Research Center at Necker-Enfants Malades Hospital (AP-HP); Sensorion and Fondation Pour l'Audition. The trial has also been submitted to other European countries and is currently undergoing assessment.
Audiogene is the first clinical trial in France to test a gene therapy drug, SENS-501, ...
Vaccine targeting KRAS in pancreatic and colorectal cancer shows promise
2024-02-02
A new vaccine shows encouraging early results as a potential off-the-shelf treatment for certain patients with pancreatic or colorectal cancer, according to a study co-led by researchers at Memorial Sloan Kettering Cancer Center (MSK). The vaccine targets tumors with mutations (or changes) in the KRAS gene, a driving force in many cancers.
This cancer vaccine is different from another type of pancreatic cancer vaccine, which is custom-made for each patient using messenger RNA (mRNA). Both are therapeutic vaccines given after surgery ...